SCHEMBL29960917

SCHEMBL29960917

CCOC(=O)C(C)(C)c1cc(Cl)ccc1Br

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCB11 O95342 1/20 0.49
▸ CYP1A2 P05177 1/20 0.49
▸ CYP3A4 P08684 1/20 0.49
▸ TSHR P16473 1/20 0.49
▸ HTR2A P28223 1/20 0.49
▸ PMP22 Q01453 1/20 0.49
▸ PPARA Q07869 1/20 0.49
▸ CNR2 P34972 4/20 0.47
▸ GAA P10253 2/20 0.44
▸ OPRK1 P41145 1/20 0.42
▸ FBP1 P09467 3/20 0.41
▸ DDR1 Q08345 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ MAOB P27338 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ MAPT P10636 2/20 0.38
▸ LMNA P02545 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30298217 0.83 KDM4E (0.40) GAADDR1KDM4EMAPK1MAPT
SCHEMBL12713184 0.78 TSHR (0.48) ABCB11CYP1A2CYP3A4TSHRHTR2A
SCHEMBL15740351 0.77 TSHR (0.47) ABCB11CYP1A2CYP3A4TSHRHTR2A
SCHEMBL6677336 0.74 ABCB11 (0.61) ABCB11CYP1A2CYP3A4TSHRHTR2A
SCHEMBL1116734 0.74 CYP1A2 (0.61) ABCB11CYP1A2CYP3A4TSHRHTR2A
SCHEMBL18512329 0.73 PTGDR2 (0.43) ABCB11CYP1A2CYP3A4TSHRHTR2A
SCHEMBL12713204 0.73 ALDH1A1 (0.43) ABCB11CYP1A2CYP3A4TSHRHTR2A
SCHEMBL27334948 0.73 DDR1 (0.40) CYP1A2CYP3A4PPARAGAADDR1
SCHEMBL1627032 0.72 TSHR (0.46) ABCB11CYP1A2CYP3A4TSHRHTR2A
SCHEMBL5096350 0.72 CYP4F2 (0.51) TSHRGAAALOX15MAOBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022204150-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERS BLUE OAK PHARMACEUTICALS, INC. (US) 2022-09-29 — — WO disclosed
Send feedback